Brewin Dolphin Wealth Management’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
CCM
Brewin Dolphin Wealth Management's SNY Position: Q2 2022 in Review
Brewin Dolphin Wealth Management sold out of Sanofi (SNY) in Q2 2022, closing a stake of 299 shares — an estimated $15K sold.
Brewin Dolphin Wealth Management first reported a position in SNY in Q1 2022 and held it in 1 quarter. The position peaked at $15K in Q1 2022. 655 funds tracked by Wall St. Rank hold SNY as of Q2 2022.
- Brewin Dolphin Wealth Management reported no remaining Sanofi position as of Q2 2022 after selling out during the quarter.
- Brewin Dolphin Wealth Management sold 299 Sanofi shares in Q2 2022, an estimated $15K.
- Brewin Dolphin Wealth Management first reported a position in Sanofi in Q1 2022 and held it in 1 quarter.
- Brewin Dolphin Wealth Management's Sanofi position peaked at $15K in Q1 2022.
- 655 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.
Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.